From: Ticking on Pandora’s box: a prospective case-control study into ‘other’ tick-borne diseases
Baseline | 4 weeks | |
---|---|---|
Written information and informed consent | X | |
Baseline characteristics | X | |
Recording of adverse events | X | X |
Laboratory measurements | ||
C6 EIA and confirmatory immunoblot – Borrelia burgdorferi s.l. | X | |
ELISA and confirmatory VNT - TBEV | X | |
IFA – Anaplasma phagocytophilum, Babesia microti, Rickettsia SFG | X | |
Immunofluorescence protein microarray – Borrelia miyamotoi | X |